Early versus late pulmonary rehabilitation in chronic obstructive pulmonary disease patients with acute exacerbations: A randomized trial

Respiration

Volumn 83, Issue 6, 2012, Pages 499-506

  Puhan, Milo A ^a,f   Spaar, Anne ^a   Frey, Martin ^b   Turk, Alexander ^c   Brändli, Otto ^c   Ritscher, Daniel ^d   Achermann, Eva ^e   Kaelin, Rainer ^c   Karrer, Werner ^c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Klinik Barmelweid   (Switzerland)

^c Zürcher Höhenklinik Wald ^*  (Switzerland)

^d Lungenpraxis Morgental   (Switzerland)

^e Limmattalspital   (Switzerland)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Chronic obstructive pulmonary disease; Exacerbation; Quality of life; Randomized trials; Rehabilitation

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

AGED; DISEASE PROGRESSION; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; MULTIVESICULAR BODIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; REFERRAL AND CONSULTATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84862754359     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000329884     Document Type: Article

References (20)

1. Celli BR, MacNee W: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
2. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, et al: American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-1413.
3. Lacasse Y, Goldstein R, Lasserson TJ, Martin S: Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; 4:CD003793.
4. Beauchamp MK, Nonoyama M, Goldstein RS, Hill K, Dolmage TE, Mathur S, Brooks D: Interval versus continuous training in individuals with chronic obstructive pulmonary disease - a systematic review. Thorax 2010; 65: 157-164.
5. Puhan MA, Schunemann HJ, Frey M, Scharplatz M, Bachmann LM: How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction. Thorax 2005; 60: 367-375.
6. Osthoff M, Leuppi JD: Management of chronic obstructive pulmonary disease patients after hospitalization for acute exacerbation. Respiration 2010; 79: 255-261.
7. Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J: Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2009; 1:CD005305.
8. Garcia-Aymerich J, Barreiro E, Farrero E, Marrades RM, Morera J, Anto JM: Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). Eur Respir J 2000; 16: 1037-1042.
9. Puhan MA, Garcia-Aymerich J, Frey M, ter Riet G, Anto JM, Agusti AG, Gomez FP, Rodriguez-Roisin R, Moons KG, Kessels AG, et al: Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374: 704-711.
10. Puhan MA, Busching G, Schunemann HJ, VanOort E, Zaugg C, Frey M: Interval versus continuous high-intensity exercise in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2006; 145: 816-825.
11. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, Renzi P, Nault D, Borycki E, Schwartzman K, et al: Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003; 163: 585-591.
12. Puhan MA, Behnke M, Frey M, Grueter T, Brandli O, Lichtenschopf A, Guyatt GH, Schunemann HJ: Self-administration and interviewer-administration of the German Chronic Respiratory Questionnaire: instrument development and assessment of validity and reliability in two randomised studies. Health Qual Life Outcomes 2004; 2: 1.
13. Puhan MA, Behnke M, Laschke M, Lichtenschopf A, Brandli O, Guyatt GH, Schunemann HJ: Self-administration and standardisation of the chronic respiratory questionnaire: a randomised trial in three German- speaking countries. Respir Med 2004; 98: 342-350.
14. Puhan MA, Behnke M, Devereaux PJ, Montori VM, Braendli O, Frey M, Schunemann HJ: Measurement of agreement on health-related quality of life changes in response to respiratory rehabilitation by patients and physicians - a prospective study. Respir Med 2004; 98: 1195-1202.
15. Spaar A, Frey M, Turk A, Karrer W, Puhan MA: Recruitment barriers in a randomized controlled trial from the physicians' perspective: a postal survey. BMC Med Res Methodol 2009; 9: 14.
16. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM: Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58: 100-105.
17. Groenewegen KH, Schols AMWJ, Wouters EFM: Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124: 459-467.
18. Seemungal T, Donaldson G, Paul E, Bestall J, Jeffries D, Wedzicha J: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-1422.
19. Roberts CM, Barnes S, Lowe D, Pearson MG: Evidence for a link between mortality in acute COPD and hospital type and resources. Thorax 2003; 58: 947-949.
20. Roberts CM, Ryland I, Lowe D, Kelly Y, Bucknall CE, Pearson MG: Audit of acute admissions of COPD: standards of care and management in the hospital setting. Eur Respir J 2001; 17: 343-349.